KCNN4
Basic information
Region (hg38): 19:43766533-43780976
Links
Phenotypes
GenCC
Source:
- dehydrated hereditary stomatocytosis 2 (Moderate), mode of inheritance: AD
- dehydrated hereditary stomatocytosis 2 (Strong), mode of inheritance: AD
- dehydrated hereditary stomatocytosis (Supportive), mode of inheritance: AD
- cystic fibrosis (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Dehydrated hereditary stomatocytosis 2 | AD | Hematologic | Individuals have been described with severe anemia, and interventions such as RBC transfusions, erythropoietin, and splenectomy may be indicated | Hematologic | 26148990; 26178367; 26198474 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn_genetic_diseases (49 variants)
- Dehydrated_hereditary_stomatocytosis_2 (48 variants)
- not_provided (40 variants)
- KCNN4-related_disorder (14 variants)
- Primary_ciliary_dyskinesia_5 (1 variants)
- Dehydrated_hereditary_stomatocytosis_with_or_without_pseudohyperkalemia_and/or_perinatal_edema (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KCNN4 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000002250.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 11 | 19 | ||||
| missense | 81 | 92 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 3 | |||||
| splice donor/acceptor (+/-2bp) | 1 | |||||
| Total | 2 | 2 | 87 | 18 | 6 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| KCNN4 | protein_coding | protein_coding | ENST00000262888 | 8 | 14725 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 5.03e-7 | 0.860 | 125494 | 2 | 251 | 125747 | 0.00101 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.62 | 194 | 269 | 0.721 | 0.0000159 | 2695 |
| Missense in Polyphen | 63 | 99.913 | 0.63055 | 1044 | ||
| Synonymous | 0.755 | 108 | 118 | 0.912 | 0.00000688 | 936 |
| Loss of Function | 1.53 | 13 | 20.5 | 0.634 | 0.00000111 | 202 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0115 | 0.0114 |
| Ashkenazi Jewish | 0.000497 | 0.000496 |
| East Asian | 0.000130 | 0.000109 |
| Finnish | 0.000231 | 0.000231 |
| European (Non-Finnish) | 0.000238 | 0.000229 |
| Middle Eastern | 0.000130 | 0.000109 |
| South Asian | 0.000164 | 0.000163 |
| Other | 0.000660 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Forms a voltage-independent potassium channel that is activated by intracellular calcium (PubMed:26148990). Activation is followed by membrane hyperpolarization which promotes calcium influx. Required for maximal calcium influx and proliferation during the reactivation of naive T-cells. The channel is blocked by clotrimazole and charybdotoxin but is insensitive to apamin (PubMed:17157250, PubMed:18796614). {ECO:0000269|PubMed:17157250, ECO:0000269|PubMed:18796614, ECO:0000269|PubMed:26148990}.;
- Disease
- DISEASE: Dehydrated hereditary stomatocytosis 2 (DHS2) [MIM:616689]: An autosomal dominant hemolytic anemia characterized by primary erythrocyte dehydration. Erythrocytes exhibit decreased total cation and potassium content that are not accompanied by a proportional net gain of sodium and water. Affected individuals typically manifest mild to moderate compensated hemolytic anemia, with an increased erythrocyte mean corpuscular hemoglobin concentration and a decreased osmotic fragility, both of which reflect cellular dehydration. Their red cells exhibit a panel of various shape abnormalities such as elliptocytes, hemighosts, schizocytes, and very rare stomatocytic cells. Complications such as splenomegaly and cholelithiasis, resulting from increased red cell trapping in the spleen and elevated bilirubin levels, respectively, may occur. {ECO:0000269|PubMed:26148990, ECO:0000269|PubMed:26178367, ECO:0000269|PubMed:26198474}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Protein digestion and absorption - Homo sapiens (human);Salivary secretion - Homo sapiens (human);Insulin secretion - Homo sapiens (human);miR-targeted genes in leukocytes - TarBase;miR-targeted genes in lymphocytes - TarBase;Polycystic Kidney Disease Pathway;Neuronal System;Ca2+ activated K+ channels;Potassium Channels
(Consensus)
Intolerance Scores
- loftool
- 0.152
- rvis_EVS
- -0.12
- rvis_percentile_EVS
- 45.13
Haploinsufficiency Scores
- pHI
- 0.168
- hipred
- N
- hipred_score
- 0.394
- ghis
- 0.499
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.600
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Kcnn4
- Phenotype
- hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); immune system phenotype; renal/urinary system phenotype; digestive/alimentary phenotype; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; muscle phenotype;
Gene ontology
- Biological process
- immune system process;potassium ion transport;calcium ion transport;cell volume homeostasis;defense response;stabilization of membrane potential;phospholipid translocation;saliva secretion;positive regulation of protein secretion;positive regulation of T cell receptor signaling pathway;potassium ion transmembrane transport
- Cellular component
- plasma membrane;voltage-gated potassium channel complex;vesicle;neuron projection;neuronal cell body
- Molecular function
- potassium channel activity;protein binding;calmodulin binding;calcium-activated potassium channel activity;small conductance calcium-activated potassium channel activity;protein phosphatase binding;Intermediate conductance calcium-activated potassium channel activity